Yu-Waye Chu, Chief Medical Officer at CytomX Therapeutics, Inc. (CTMX), sold 4,025 shares at $0.60 ($2K) on 2025-03-18, disclosed to the SEC on 2025-03-20.
Open-market sale of $2k CTMX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| FATE | SELL | 2023-01-11 | $41K | — | Filing → |
| FATE | SELL | 2022-04-21 | $287K | — | Filing → |
| FATE | SELL | 2022-01-13 | $364K | — | Filing → |